Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Other Working Capital Changes: 2023-2024

Historic Other Working Capital Changes for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $7.7 million.

  • Zenas BioPharma's Other Working Capital Changes rose 189.44% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 587.77%. This contributed to the annual value of $7.7 million for FY2024, which is 129.95% up from last year.
  • Zenas BioPharma's Other Working Capital Changes amounted to $7.7 million in FY2024, which was up 129.95% from $3.3 million recorded in FY2023.
  • Over the past 5 years, Zenas BioPharma's Other Working Capital Changes peaked at $7.7 million during FY2024, and registered a low of $3.3 million during FY2023.
  • Over the past 2 years, Zenas BioPharma's median Other Working Capital Changes value was $5.5 million (recorded in 2023), while the average stood at $5.5 million.
  • Data for Zenas BioPharma's Other Working Capital Changes shows a peak YoY soared of 129.95% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Other Working Capital Changes stood at $3.3 million in 2023, then spiked by 129.95% to $7.7 million in 2024.